What Happened?
Cambridge, MA-based Pyxis-Oncology Promoted Jan Pinkas as Senior Vice President, Preclinical Research and Development and Chief Scientific Officer
About the Company
Founded by Longwood Fund, Pyxis Oncology is building a differentiated portfolio of biologics, including antibody-drug conjugates (ADCs) and immunotherapies, to improve the lives of patients with difficult-to-treat cancers. Pyxis is employing site-specific conjugation technology to develop highly stable ADCs with enhanced therapeutic indexes. Pyxis is also advancing a diverse portfolio of immunotherapies that target broad immune regulators as well as novel immune checkpoints identified through its immuno-oncology and cold tumor discovery efforts.
About the Person
Jan Pinkas is Senior Vice President, Preclinical Research and Development and Chief Scientific Officer at Pyxis Oncology. Previously, Jan held various senior HR leadership roles in the industry.
Info Source
News
Short Profile